Bio Briefs
Posted By
Recent Posts on This Topic | See All >
-
Jan 03, 2012 Nature speaks with Keim about H5N1 studies Tags: h5n1, northern arizona university, paul keim, tgen north -
-
-
Jun 20, 2011 Promising skin-cancer drug nears approval Tags: daniel von hoff, scottsdale healthcare, tgen
Infection-fighting antibodies made in plants as effective as costlier conventional version
Tags: arizona state university, biodesign institute, infectious disease[Source: ScienceDaily] - The first head-to-head comparison of therapeutic monoclonal antibodies produced from plants versus the same antibodies produced from mammalian cells has shown that plant-produced antibodies can fight infection equally well.
Scientists from Washington University School of Medicine in St. Louis and Arizona State University conducted the comparison as a test of the potential for treating disease in developing nations with the significantly less expensive plant-based production technique. The results are reported online in the Proceedings of the National Academy of Sciences.
Antibodies, which are part of the immune system, bind to foreign invaders to disable them and label them for destruction. Because of their finely tuned targeting capabilities, scientists have developed ways to mass-produce a particular antibody. They have used such monoclonal antibodies in a variety of contexts.
For more information: Infection-Fighting Antibodies Made in Plants as Effective as Costlier Conventional Version
Quick Links
![]()
Download a new brochure from the Flinn Foundation outlining the 2011 progress on Arizona's Bioscienced Roadmap: a record high in bioscience jobs, plus gains in firms and venture-capital funding. Numerous achievements during the year advanced the core strategies of the Roadmap.
Also, read the full Performance Assessment describing in detail Arizona's 2011 progress on key Roadmap metrics.


Share on Twitter
Share on Facebook


